COVIRIX Medical says its broad-spectrum antiviral portfolio has already shown positive virology results against key pandemic threats
Expanded capabilities that continue to push the boundaries of innovation—advancing drug delivery solutions for patients, customers, and consumers around the world
Agreement further expands Aptar Pharma’s leading position in nasal delivery solutions and addresses significant unmet needs of delivering drugs locally over extended periods
Agreement further expands Aptar Pharma’s leading respiratory portfolio
APF Futurity is made from polyolefin materials with no metal parts or recycling disruptors
The expansion program includes investments in France and the U.S., adding an additional 23,000+ m² of manufacturing footprint.
The companies will leverage their respective proprietary technology platforms
The collaboration highlights the rising importance of intranasal delivery in developing non-vaccine approaches to respiratory disease prevention
Sommaplast’s portfolio includes closures, droppers, dispensers and dosing cups, supporting a broad range of oral dosing applications
SmartTrack aims to reduce the need for clinical studies in generic drug product approvals
Subscribe To Our Newsletter & Stay Updated
